| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.09 |